Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
26-Oct-26
$20m
$20mEST
26-Oct-28
On October 26, 2026, the Board authorized us to repurchase an indeterminate number of common shares and Series A Preferred Shares at an aggregate market value of up to $20.0 million during a two-year period that will expire on October 26, 2028.10-Q filed 13-Nov-26
28-Oct-24
$20m
$9m
28-Oct-26
On October 29, 2024, the Company announced that on October 28, 2024, the Board authorized a share repurchase program through which the Company may repurchase an indeterminate number of common shares and Series A Preferred Shares at an aggregate market value of up to $20.0 million during a two-year period that expired on October 28, 2026.10-Q filed 13-Nov-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)